As of a September 25, 2025 data cut-off-date, 10 patients with treatment-refractory, moderate-to-severe Systemic Lupus Erythematosus (SLE) were ...

SLE patients with lupus nephritis (LN) surpassing a 3-month post-treatment time point (n=2) achieved complete renal response (CRR) at 6 months; first patient continues in drug-free Definition of ...

Peripheral neuropathy can be a symptom of chronic Lyme disease, causing burning, tingling, and numbness in extremities Traditional treatments often fail because they don’t address the complex nature ...

The move aims to regulate cell and gene therapies, and xenografts or animal-to-human transplants. Such therapies are ...

The integration of Bruton tyrosine kinase (BTK) inhibitors into first-line treatment regimens, in combination with ...

The same cell product could potentially be used to treat multiple solid tumors like ovarian, pancreatic and lung cancers.

So far, immune cells that have been engineered to kill cancers, known as CAR T-cells, haven’t worked well against solid ...

Researchers from Memorial Sloan Kettering Cancer Center (MSK) presented new studies related to a range of cancer types at the ...

GV- and Arch-backed Pelage Pharma is developing a first-of-its-kind topical stem-cell therapy that could redefine the $10B ...

Abstract: We evaluated and designed the canted angle and magnetic properties of canted spin-orbit torque (SOT) MRAM cells fabricated in a 300mm CMOS fully compatible process. In the results, we ...